Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 

Review of Hepatitis C Therapy in Genotype 1 Patients


Date: Apr 20, 2016 12:30 PM - 01:30 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Apr 20, 2016 10:00 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacist

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

CPE Monitor: Requirement to Track your CPE
Important new requirement from the Accreditation Council for Pharmacy Education and the National Association of Boards of Pharmacy for all pharmacists and technicians who obtain CPE credit. The CPE Monitor system will securely track all your completed CPE credits in a central system.

https://store.nabp.net/OA_HTML/xxnabpibeGblLogin.jsp 

 

 

Registration closes on Apr 20, 2016 at 10:00 PM

Registration Closed  

Objectives

  • Demonstrate an understanding of current Hepatitis C drug regimen efficacy and safety outcomes compare to previous interferon-based regimens.
  • Define specific factors and parameters to be considered prior initiation of hepatitis C treatment and choice of a regimen.
  • Recognize the challenges and monitoring parameters when treating a unique patient population of HCV Infected patients (renal failure, HIV/HCV co-infected, decompensated cirrhotic, or transplant patients).

Speaker(s)/Author(s)

Pierre Ndje, Pharm.D., Pharm.D.
PGY1 Pharmacy Resident, Veterans Affair Medical Center

Activity Number

0010-0000-16-001-L01-P
Date: 04/20/16
Time: 12:30 PM - 01:30 PM

CE Hours

1.00

Location

Howard University College of Pharmacy
Registration Closed